摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-溴苯基)吡啶-2-酮 | 7661-32-7

中文名称
1-(4-溴苯基)吡啶-2-酮
中文别名
1-(4-溴苯基)2-吡咯烷酮;1-(4-溴苯基)2-吡咯烷酮
英文名称
1-(4-bromophenyl)pyrrolidin-2-one
英文别名
1-(4-bromophenyl)-2-pyrrolidinone
1-(4-溴苯基)吡啶-2-酮化学式
CAS
7661-32-7
化学式
C10H10BrNO
mdl
MFCD00138502
分子量
240.099
InChiKey
YINFEFUSAQRZGG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    98-101 °C
  • 沸点:
    98-101°C
  • 密度:
    1.4808 (rough estimate)
  • 闪点:
    98-101°C
  • 稳定性/保质期:
    如果按照规格正确使用和储存,则不会分解,请避免接触氧化物。

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi
  • 安全说明:
    S24/25
  • 海关编码:
    2933790090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302
  • 储存条件:
    保持贮藏器密封,并将其放入一个紧密的容器中。储存时,请放置在阴凉、干燥处。

SDS

SDS:112bd4d6c3ce6bcba3194ea73552f4fc
查看
Name: 1-(4-Bromophenyl)-2-Pyrrolidinone 99+%(GC) Material Safety Data Sheet
Synonym: None Known
CAS: 7661-32-7
Section 1 - Chemical Product MSDS Name:1-(4-Bromophenyl)-2-Pyrrolidinone 99+%(GC) Material Safety Data Sheet
Synonym:None Known

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
7661-32-7 1-(4-Bromophenyl)-2-Pyrrolidinone 99+% unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 7661-32-7: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: beige
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 98.00 - 101.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H10BrNO
Molecular Weight: 240.10

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, hydrogen bromide.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 7661-32-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(4-Bromophenyl)-2-Pyrrolidinone - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 7661-32-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 7661-32-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7661-32-7 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(4-溴苯基)吡啶-2-酮 在 palladium on activated charcoal chiral oxaziridine 、 氢气三乙胺lithium hexamethyldisilazane三氯氧磷 作用下, 以 四氢呋喃甲醇二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 62.5h, 生成 MYOSINII抑制剂((-)-BLEBBISTATIN)
    参考文献:
    名称:
    小分子工具 (-)-Blebbistatin 的绝对立体化学分配和荧光调谐
    摘要:
    (-)-Blebbistatin (1) 是最近发现的非肌肉肌球蛋白 II ATPase 活性的小分子抑制剂,已从 5-甲基邻氨基苯甲酸甲酯 (6) 分三步制备。这种灵活的合成路线也已被用于制备含硝基的类似物 12,该类似物在显微镜照明下具有改进的荧光特性和改进的稳定性。合成 1 及其类似物的关键步骤是使用 Davis oxaziridine 方法对喹诺酮中间体 3 进行不对称羟基化。通过对含有类似物 11 的重原子(溴)进行 X 射线晶体结构分析,(-)-blebbistatin (1) 的绝对立体化学显示为 S,随后将其还原并显示与 1 相同。
    DOI:
    10.1002/ejoc.200500103
  • 作为产物:
    描述:
    1-苯基-2-吡咯烷酮N-溴代丁二酰亚胺(NBS) 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 48.0h, 以50%的产率得到1-(4-溴苯基)吡啶-2-酮
    参考文献:
    名称:
    小分子工具 (-)-Blebbistatin 的绝对立体化学分配和荧光调谐
    摘要:
    (-)-Blebbistatin (1) 是最近发现的非肌肉肌球蛋白 II ATPase 活性的小分子抑制剂,已从 5-甲基邻氨基苯甲酸甲酯 (6) 分三步制备。这种灵活的合成路线也已被用于制备含硝基的类似物 12,该类似物在显微镜照明下具有改进的荧光特性和改进的稳定性。合成 1 及其类似物的关键步骤是使用 Davis oxaziridine 方法对喹诺酮中间体 3 进行不对称羟基化。通过对含有类似物 11 的重原子(溴)进行 X 射线晶体结构分析,(-)-blebbistatin (1) 的绝对立体化学显示为 S,随后将其还原并显示与 1 相同。
    DOI:
    10.1002/ejoc.200500103
点击查看最新优质反应信息

文献信息

  • Combining Eosin Y with Selectfluor: A Regioselective Brominating System for <i>Para</i>-Bromination of Aniline Derivatives
    作者:Binbin Huang、Yating Zhao、Chao Yang、Yuan Gao、Wujiong Xia
    DOI:10.1021/acs.orglett.7b01427
    日期:2017.7.21
    A mild, metal-free, and absolutely para-selective bromination of aniline derivatives has been developed in excellent yields, wherein the organic dye Eosin Y is employed as the bromine source in company with Selectfluor. Neither air nor moisture sensitive, this facile reaction proceeds smoothly at room temperature and completes within a short time. Mechanistic studies indicate a radical pathway; therefore
    已开发出具有优异收率的温和,无金属且绝对对位选择性的苯胺衍生物溴化物,其中有机染料曙红Y与Selectfluor一起用作溴源。无论是对空气还是对湿气都不敏感,这种反应很容易在室温下进行并在短时间内完成。机理研究表明了一条根本途径。因此,的原位产生的溴化试剂的存在,“Selectbrom”,是假设,可合理解释为独特区域选择性段的-bromination Ñ -acyl-以及Ñ -sulfonylanilines。
  • Solvent-free aromatic C–H functionalisation/halogenation reactions
    作者:Robin B. Bedford、Jens U. Engelhart、Mairi F. Haddow、Charlotte J. Mitchell、Ruth L. Webster
    DOI:10.1039/c0dt00385a
    日期:——
    The solvent-free, palladium-catalysed reaction of anilides with CuCl2 in the presence or absence of copper acetate yields ortho-chlorinated anilides in good to excellent yields, even on a large scale (100 mmol). By contrast, the equivalent reactions with copper bromide, either solvent free or in 1,2-dichloroethane, in the presence or absence of palladium, under air or inert conditions, gave the products
    无溶剂 钯催化的苯甲酸酯与 氯化铜2 在存在或不存在的情况下 醋酸铜即使大规模(100 mmol),也能以良好或优异的收率得到邻氯代苯甲酸酯。相比之下,与溴化铜,无溶剂或在 1,2-二氯乙烷,无论是否存在 钯在空气或惰性条件下,得到简单的亲电子溴化产物。机理研究突显了Palladacyclic中间体的参与,其中之一在结晶学上已得到表征,随后会与之发生反应。铜(II),氯化 产生氯化苯胺产品。
  • A <i>para</i> -C-H Functionalization of Aniline Derivatives via In situ Generated Bulky Hypervalent Iodinium Reagents
    作者:Chao Tian、Xu Yao、Weizhe Ji、Qian Wang、Guanghui An、Guangming Li
    DOI:10.1002/ejoc.201801058
    日期:2018.11.25
    A general para‐selective C‐H functionalization was achieved via a steric control strategy. Para‐iodo, bromo, chloro, nitro, and trifluormethyl aniline derivatives were prepared via in situ generated, bulky hypervalent iodinium reagents in as little as 10 min. Products can be purified without column chromatography or recrystallization, which significantly reduces the waste and simplifies the work‐up
    通过空间控制策略可实现一般的对选择性C-H功能化。对碘,溴,氯,硝基和三氟甲基苯胺衍生物可在短短10分钟内通过原位生成的大体积高价碘试剂制备。无需柱色谱或重结晶即可纯化产品,从而大大减少了浪费并简化了后处理过程。
  • Scope and selectivity in palladium-catalyzed directed C–H bond halogenation reactions
    作者:Dipannita Kalyani、Allison R. Dick、Waseem Q. Anani、Melanie S. Sanford
    DOI:10.1016/j.tet.2006.06.075
    日期:2006.12
    Palladium-catalyzed ligand directed C–H activation/halogenation reactions have been extensively explored. Both the nature of the directing group and the substitution pattern on the arene ring of the substrate lead to different reactivity profiles, and often different and complementary products, in the presence and absence of the catalyst.
    钯催化的配体定向的C–H活化/卤化反应已得到广泛研究。在存在和不存在催化剂的情况下,导向基团的性质和底物的芳环上的取代图案均导致不同的反应性分布,并且常常导致不同的和互补的产物。
  • Rhodium(III)-Catalyzed C-H Vinylation of Arenes: Access to Functionalized Styrenes
    作者:Jun Zhou、Xin Li、Gang Liao、Bing-Feng Shi
    DOI:10.1002/cjoc.201800354
    日期:2018.12
    An effective method has been developed for Rh(III)‐catalyzed direct vinylation of arenes to give functionalized styrenes, using vinyltriethoxysilane as a convenient and inexpensive vinyl source. A wide variety of substrates, including 1‐aryl‐2‐pyrrolidinones, anilines, benzamides and ketones, were compatible with this reaction. Moreover, this method can be applied to the two‐step synthesis of functionalized
    已开发出一种有效的方法,可使用乙烯基三乙氧基硅烷作为方便,廉价的乙烯基来源,对Rh(III)催化的芳烃进行直接乙烯基化,以生成官能化的苯乙烯。此反应兼容多种底物,包括1-芳基-2-吡咯烷酮,苯胺,苯甲酰胺和酮。而且,该方法可以应用于功能化吲哚的两步合成。机理研究表明该反应可能通过氧化性Heck /去甲硅烷基化途径进行。
查看更多

同类化合物

(2R,2''R)-(-)-2,2''-联吡咯烷 麦角甾-7,22-二烯-3-基亚油酸酯 马来酰亚胺霉素 马来酰亚胺基甲基-3-马来酰亚胺基丙酸酯 马来酰亚胺丙酰基-dPEG4-NHS 马来酰亚胺-酰胺-PEG6-琥珀酰亚胺酯 马来酰亚胺-酰胺-PEG24-丙酸 马来酰亚胺-酰胺-PEG12-丙酸 马来酰亚胺-四聚乙二醇-羧酸 马来酰亚胺-四聚乙二醇-丙酸叔丁酯 马来酰亚胺-六聚乙二醇-丙酸叔丁酯 马来酰亚胺-二聚乙二醇-丙酸叔丁酯 马来酰亚胺-三(乙烯乙二醇)-丙酸 马来酰亚胺-一聚乙二醇-羧酸 马来酰亚胺-一聚乙二醇-丙烯酸琥珀酰亚胺酯 马来酰亚胺-PEG3-羟基 马来酰亚胺-PEG2-胺三氟醋酸盐 马来酰亚胺-PEG2-琥珀酰亚胺酯 马来酰亚胺 频哪醇硼酸酯 顺式4-甲基吡咯烷酮-3-醇盐酸盐 顺式3,4-二氨基吡咯烷-1-羧酸叔丁酯 顺式-二甲基 1-苄基吡咯烷-3,4-二羧酸 顺式-N-[2-(2,6-二甲基-1-哌啶基)乙基]-2-氧代-4-苯基-1-吡咯烷乙酰胺 顺式-N-Boc-吡咯烷-3,4-二羧酸 顺式-5-苄基-2-叔丁氧羰基六氢吡咯并[3,4-c]吡咯 顺式-4-氧代-六氢-吡咯并[3,4-C]吡咯-2-甲酸叔丁酯 顺式-3-氟-4-羟基吡咯烷-1-羧酸叔丁酯 顺式-3-氟-4-甲基吡咯烷盐酸盐 顺式-2-甲基六氢吡咯并[3,4-c]吡咯 顺式-2,5-二甲基吡咯烷 顺式-1-苄基-3,4-吡咯烷二甲酸二乙酯 顺式-(9CI)-3,4-二乙烯-1-(三氟乙酰基)-吡咯烷 顺-八氢环戊[c]吡咯-5-酮盐酸盐 非星匹宁 阿维巴坦中间体1 阿曲生坦中间体 阿曲生坦 间甲氧基苯乙腈 铂(2+)羟基乙酸酯-吡咯烷-3-胺(1:1:1) 钾2-氧代吡咯烷-1-磺酸酯 钠1-[(9E)-9-十八碳烯酰基氧基]-2,5-二氧代-3-吡咯烷磺酸酯 金刚烷-1-基(吡咯烷-1-基)甲酮 酸-1-吡咯烷-1,4-氨基-2-甲基-1,1,1-二甲基乙基酯,(2S,4R)- 酚丙氢吡咯 试剂3-Mercaptopropanyl-N-hydroxysuccinimideester 西他利酮 血红素酸 螺虫乙酯残留代谢物Mono-Hydroxy 萘吡坦